Review of Alzheimer's disease drugs and their relationship with neuron-glia interaction
ReviewHumansOther animals
- Design
- Review
- Subjects
- Not applicable; a narrative review
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- How Alzheimer's disease drugs, including palmitoylethanolamide, act on neuron-astrocyte-microglia interactions: pharmacokinetics, mechanism, dosing and clinical presentation across donepezil, choline alphoscerate, galantamine, dextromethorphan, palmitoylethanolamide, citalopram, resveratrol and solanezumab.
What the authors reported
The abstract gives no specific findings on palmitoylethanolamide. The authors summarise donepezil, choline alphoscerate, galantamine, dextromethorphan, palmitoylethanolamide, citalopram, resveratrol and solanezumab by pharmacokinetics, mechanism, dosing and clinical presentation.
Limits of this study
A narrative review, not new data. The abstract gives no detail on PEA evidence. The authors declare no conflict of interest.
Source
PubMed 36593897 · doi:10.1016/j.ibneur.2022.11.005
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.